SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-043747
Filing Date
2023-12-05
Accepted
2023-12-05 17:20:27
Documents
1
Period of Report
2023-12-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4152
  Complete submission text file 0001493152-23-043747.txt   5577
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Issuer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 RIDGE ROAD TUXEDO PARK NY 10987
Business Address
Farley Chele Chiavacci (Reporting) CIK: 0001908750 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 231467636